The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
|Articles|October 11, 2021
Pharmacy Clinical Pearl of the Day: Seizures
Author(s)Saro Arakelians, PharmD
Types of seizure include focal seizures with impaired awareness, generalized seizures without loss of consciousness, and generalized seizures, such as absence seizures.
Advertisement
Clinical Pearl of the Day: Seizures
A seizure is a sudden, uncontrolled electrical disturbance in the brain.
Insight:
- Symptoms include temporary confusion, a staring spell, uncontrollable jerking movement, loss of consciousness or awareness, fear, and anxiety.
- Types include focal seizures with impaired awareness; generalized seizures without loss of consciousness; and generalized seizures, including absence seizures, tonic seizures, atonic seizures, clonic seizures, myoclonic seizures, and tonic-clonic seizures
- Causes may include high fever, lack of sleep, flashing lights, low blood sodium, head trauma, autoimmune disorders, stroke, brain tumor, alcohol misuse, and viral infections.
- Treatment options may include carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, gabapentin, topiramate, phenobarbital and zonisamide.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
The FDA approval of pritelivir offers an oral treatment for refractory HSV lesions in immunocompromised adults, with drug interactions creating an important role for pharmacists.
Weltruza, the first subcutaneous long-acting injectable (LAI) formulation of olanzapine, requires no loading doses, oral supplementation, or postinjection monitoring.
Eric Lawitz, MD, explains how pharmacists can raise liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
What Different Communities Taught Me About Patient Care
3
Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC
4
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
5